During the past decade, Augusta Health Center for Cancer and Blood Disorders conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 10 clinical trials were completed, i.e. on average, 30.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 10 clinical trials were completed. i.e. 90.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Augusta Health Center for Cancer and Blood Disorders" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "NRG Oncology" with 4 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "SWOG Cancer Research Network" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Augusta Health Center for Cancer and Blood Disorders" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Augusta Health Center for Cancer and Blood Disorders" are "Breast Cancer" (3 trials), "Invasive Breast Carcinoma" (3 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (3 trials), "Recurrent Breast Carcinoma" (3 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Augusta Health Center for Cancer and Blood Disorders" in a lesser frequency.

Most popular intervention types in "Augusta Health Center for Cancer and Blood Disorders" are "Other" (31 trials), "Drug" (27 trials), "Biological" (13 trials), "Procedure" (13 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (13 trials), "Biospecimen Collection" (10 trials), "Laboratory Biomarker Analysis" (10 trials), "Questionnaire Administration" (10 trials) and "Computed Tomography" (8 trials). Other intervention names were less common.

The vast majority of trials in "Augusta Health Center for Cancer and Blood Disorders" are 30 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Augusta Health Center for Cancer and Blood Disorders". undefined are not yet recruiting, 15 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Augusta Health Center for Cancer and Blood Disorders, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Augusta Health Center for Cancer and Blood Disorders, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".